DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Llovet JM, Ricci S, Mazzaferro V , et al.
Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a Phase III randomized placebo-controlled trial (SHARP trial).
Paper presented at: American Society of Clinical Oncology Annual Meeting; June 1–5, 2007; Chicago, IL
We do not assume any responsibility for the contents of the web pages of other providers.